## LYB: LyondellBasell Industries N.V. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -2.9% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($40.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. Price-Driven Insight from (LYB) for Rule-Based Strategy**
- Source: Stock Traders Daily | 20251221T174400 | Bearish | Relevance: 100%
- This article provides a price-driven insight for Lyondellbasell Industries Nv Class A (NYSE: LYB), highlighting weak sentiment across all horizons which supports a short bias. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, and recommends watching for resistance tests and potential support levels.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $45 | $55 | -18% |
| 2025-12-18 | Citigroup | $40 | $43 | -7% |
| 2025-12-15 | BMO Capital | $36 | $48 | -25% |
| 2025-12-11 | Mizuho | $49 | $52 | -6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | down | Equal-Weight |
| 2025-12-18 | Citigroup | main | Neutral |
| 2025-12-15 | BMO Capital | down | Underperform |
| 2025-12-11 | Mizuho | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.25M) |
| Sells | 8 ($0.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.3%)
- Blackrock Inc.: 9.0% (+12.4%)
- Dodge & Cox Inc.: 5.3% (-0.0%)
- State Street Corpora: 4.1% (+2.1%)
- Capital World Invest: 3.0% (+13.1%)

### Key Risks

1. Long-term trend broken: trading 20.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.80 indicates undervaluation relative to growth. Forward P/E 12.5x attractive for 47% earnings growth. Analyst sentiment negative (4 target cuts vs 0 raises).

| Metric | Value |
|--------|-------|
| Market Cap | $14.0B |
| Beta | 0.74 |
| 52W Range | $41.58 - $79.39 |
| Short Interest | 7.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.80 |
| Forward P/E | 12.5 |
| Current P/E | 18.4 |
| YoY Growth | 47.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at -2.9% (minimal 5-day change). Below STRENGTH zone by 6.9pp (needs >4.0% for momentum thesis). Underperforming sector by 4.8pp, stock-specific weakness. Below SMA200 (0.79x), long-term trend not supportive. RSI neutral at 46. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.89% (CS: 19) | Weak |
| RSI_14 | 45.9 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 0.971x | Below |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 0.791x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $43.59
- **Stop Loss:** $40.27 (7.6% risk)
- **Target:** $46.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 271
- **Position Value:** $11,812.89
- **Portfolio %:** 11.81%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-30 (Est: $0.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.80 | $1.01 | +25.9% |
| 2025Q2 | $0.78 | $0.62 | -20.8% |
| 2025Q1 | $0.43 | $0.33 | -24.0% |
| 2024Q4 | $0.70 | $0.75 | +6.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*